Drug Search Results

Penfluridol

Alternative Names: penfluridol
Latest Update: 2024-05-02
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Erasmus Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Penfluridol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Psychotic Disorders

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
The One for Seven Study	P3	Terminated	Psychotic Disorders	2018-09-23

Recent News Events

Date	Type	Title
05/02/2024	PubMed	The Antipsychotic Drug Penfluridol Inhibits N-Linked Glycoprotein Processing and Enhances T-cell-Mediated Tumor Immunity.
03/01/2024	PubMed	Validation of spectrophotometric and colorimetric methods to quantify clindamycin in skin tissue: application to in vitro release and ex vivo dermatokinetic studies from separable effervescent microarray patch loaded bacterially sensitive microparticle.
12/15/2023	PubMed	A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: Repurposing drugs to disrupt 14-3-3 protein-BAD interactions.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions